Author

Amanda Burbank

465 posts

Amanda J. Burbank is a poet, writer and editor. She's had a number of pieces published in a variety of places, from local papers and magazines to online blogs to literary magazines. She's worked on the other side of the profession as well, from beta reading for multiple aspiring novelists to assisting a literary agent to working as an editor herself. She's also worked as a teacher, homeschooling her three children for three years, learning with them as they were continually, joyously discovering. She graduated from Huntingdon College with a bachelor of arts majoring in English and Psychology. She and her husband and children live in Wetumpka, Alabama.

Calculating necessity of statin prescription still controversial

Back in 2013, when the American Heart Association and the American College of Cardiology recommended millions more Americans be eligible for cholesterol-reducing statins, controversy stirred. People ages 40 to 75 who were otherwise healthy but whose 10-year risk of developing heart disease was determined to be 7.5 percent or higher were encouraged to take statins as preventative treatment. New guidelines that focused beyond cholesterol levels identified those who were at risk, and an online risk calculator was introduced. This class of drugs, which includes the widely prescribed Lipitor, had long been prescribed to treat heart disease, but with statins being ... Read More

How will the FDA ruling impact TVM litigation?

The U.S. Food and Drug Administration’s (FDA) two orders issued this week, reclassifying transvaginal mesh (TVM) as a high-risk device for treating Pelvic Organ Prolapse (POP) and ordering manufacturers to submit a rigorous premarket approval (PMA) application demonstrating safety and effectiveness within the next 30 months, are, according to the agency’s press announcement, based on thousands of reports of adverse events related to mesh used for urogynecological procedures in the past several years. “The FDA ruling confirms what we have been seeing from Plaintiffs in this litigation – transvaginal mesh used to treat pelvic organ prolapse is responsible for serious, chronic injuries for ... Read More

Diet-to-Go launches meal delivery product designed for people with Type 2 diabetes

Most Americans suffering from illnesses such as diabetes and high blood pressure are aware of the huge impact diet and exercise can have on their health. But for many, their schedules leave them feeling overwhelmed with the perceived rigors of meal planning, shopping and cooking, not to mention simply slowing down to sit and eat. Often the easier solution seems to be medication, but medications can carry with them serious health risks. For example, studies have shown that using statins like Lipitor, one of the most common medicines on the market prescribed for lowering and controlling cholesterol, which is linked ... Read More

Talc danger is latest health risk to tarnish Johnson & Johnson image

Reports that products from consumer health care giant Johnson & Johnson contained cancer-causing chemicals surfaced in a CBS News report in 2011. That report said that international coalition The Campaign for Safe Cosmetics had been urging the world’s largest health care company for two and a half years to remove the trace amounts of potentially cancer-causing chemicals — dioxane and a substance called quaternium-15 that releases formaldehyde — from Johnson’s Baby Shampoo without success. At that time, The Coalition was releasing a report, “Baby’s Tub is Still Toxic” and urging consumers to boycott. Johnson & Johnson vaguely stated in response that ... Read More

Ovarian Cancer victim plans a Rollicking Farewell to Fight a Quiet Killer

Ovarian cancer is quiet in its coming, then often swift and shocking. Thirty-four-year-old Inverness, Scotland, resident Michelle Campbell went in for treatment of irritable bowel syndrome this January, but began chemo in April after an inoperable tumor was found, and lost her battle with cancer just after Christmas, less than a year later. Ovarian cancer, with vague symptoms and no early-detection screening method, is usually advanced when diagnosed. It is the leading cause of death from gynecologic cancers in the United States and is the seventh most common cancer in women worldwide. Doctors had initially dismissed the possibility of cancer because ... Read More